CAS: 1346133-08-1
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
LY-2795050 REF: AN-AG009CCVCAS: 1346133-08-1 | 97% | To inquire | Thu 16 May 24 | |
LY2795050 REF: TM-TQ0091CAS: 1346133-08-1 | 97.77% | 86.00 €~698.00 € | Thu 23 May 24 | |
LY2795050 REF: 3D-WDC13308CAS: 1346133-08-1 | Min. 95% | To inquire | Thu 27 Jun 24 |
Ref: AN-AG009CCV
1mg | To inquire | |
2mg | To inquire | |
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Thursday 16 May 2024
LY2795050
CAS:1346133-08-1
LY2795050 is a novel specific κ-Opioid Receptor antagonist (IC50: 0.72 nM).
Formula:
C23H22ClN3O2
Purity:
97.77%
Color and Shape:
Solid
Molecular weight:
407.89
Ref: TM-TQ0091
1mg | 86.00 € | |
2mg | 113.00 € | |
5mg | 185.00 € | |
10mg | 296.00 € | |
25mg | 485.00 € | |
50mg | 698.00 € | |
1ml*10 (DMSO) | 201.00 € |
Estimated delivery in United States, on Thursday 23 May 2024
LY2795050
CAS:1346133-08-1
LY2795050 is a drug that acts as a δ receptor agonist. It has been shown …
Formula:
C23H22ClN3O2
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
407.89 g/mol
Ref: 3D-WDC13308
1mg | To inquire | |
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire |
Estimated delivery in United States, on Thursday 27 Jun 2024